Wall Street analysts who follow Viking and Summit expect further gains in 2025. Quick gains are often lost on Wall Street, ...

U.S. pharma giant Merck & Co., Inc., or MSD, obtained an exclusive global license to develop, manufacture and commercialize ...

Shares of Merck & Co. Inc. MRK inched 0.74% higher to $102.00 Friday, on what proved to be an all-around mixed trading ...

At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits ...

Page Valley News (PageValleyNews.com) is an online local news site and an independent, locally owned community website ...

EU regulators recommend approval of Merck's drug Welireg for certain patients with VHL disease or advanced kidney cancer.

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...

Bicycle Therapeutics presented data on zelenectide pevedotin, highlighting enhanced efficacy in cancer patients with NECTIN4 ...

(RTTNews) - Drug major Merck & Co., Inc. (MRK) announced Friday that its WELIREG (belzutifan) has received positive opinion from the European Medicines Agency's Committee for Medicinal Products for ...

BofA Securities has recently resumed Merck & Co Inc (MRK) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on December 4, 2024, HSBC Securities had raised the ...

The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D ...

PeptiDream, the Japanese biopharma with a penchant for deal-making, has a new bargaining chip in its hand in the red-hot ...